Determinants of the natural history of human immunodeficiency virus type 1 infection

Journal of Infectious Diseases

Volumn 179, Issue SUPPL. 2, 1999, Pages

  Phair, John P ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONFERENCE PAPER; DISEASE MARKER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE COUNT; MALE; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION;

EID: 0033390720     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/513839     Document Type: Conference Paper

References (34)

1. + lymphocyte counts and p24 antigenemia. Am J Med 1990;89:706-12.
2. 2. Redfield R, Wright JD, Tramont E. The Walter Reed staging classification for HTLV-II/LAV infection. N Engl J Med 1986;314:131-2.
3. 3. MacDonell K, Chmiel J, Goldsmith J, et al. Prognostic usefulness of the Walter Reed staging classification of HIV infection. J AIDS 1988;1: 367-74.
4. 4. Fahey J, Taylor J, Detels R, et al. The prognostic value of cellular and serologie markers in infection with human immunodeficiency virus type-1. N Engl J Med 1990;322:166-72.
5. 5. Kirby AJ, Muñoz A, Detels R, et al. Thrush and fever as measures of immunocompetence in HIV-1 infected men. J Acquir Immune Defic Syndr 1994;7:1242-9.
6. 6. Clark SJ, Saag MS, Decker D, et al. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med 1991;324:954-60.
7. 7. Henrard DR, Wu S, Phillips J, Wiesner D, Phair JP. Detection of p24 antigen with and without immune complex dissociation for longitudinal monitoring of human immunodeficiency virus type-1 infection. J Clin Microbiol 1995;33:72-5.
8. + lymphocyte number, and AIDS-free time. J Infect Dis 1992;166:1217-22.
9. + lymphocytes in HIV-1 infection. Nature 1995;373: 123-6.
10. 10. Wei X, Ghosh S, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type-1 infection. Nature 1995;373:117-22.
11. 11. O'Brien T, Blattner W, Walters D, et al. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA 1996;276:105-10.
12. + lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996;334:426-31.
13. + lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126:949-54.
14. 14. Kaslow R, Ostrow D, Detels R, et al. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987;126:310-8.
15. 15. Giorgi JU, Cheng HL, Margolick JB, et al. Quality control in the flow cytometric measurement of T-lymphocyte subsets. The Multicenter AIDS Cohort Experience. Clin Immunol Immunopathol 1990;55:173-86.
16. 16. Graham MM, Jacobson LP, Kuo U, et al. Access to therapy in the Multicenter AIDS Cohort Study 1988-1992. J Clin Epidemiol 1994;47:1003-12.
17. 17. Muñoz A, Sabin CA, Phillip AN. The incubation period of AIDS. AIDS 1997;11(suppl):S69-76.
18. 18. Phair J, Jacobson L, Detels R, et al. Acquired immune deficiency syndrome occurring within five years of infection with human immunodeficiency virus type-1. J Acquir Immune Defic Syndr 1992;5:490-6.
19. 19. Zhu T, Mo H, Wang N, et al. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993;216:1179-81.
20. 20. Phair JP, Margolick JB, Jacobson LP, et al. Detection of infection with human immunodeficiency virus type 1 before seroconversion: correlation with clinical symptoms and outline. J Infect Dis 1997;175:959-62.
21. 21. Pantaleo G, Graziosi C, Fauci A. The immunopathogenesis of human immunodeficiency virus infections. N Engl J Med 1993;328:327-35.
22. 22. Wolinsky S, Korber B, Neumann A, et al. Adaptive evaluation of human immunodeficiency virus type 1 during the natural course of infection. Science 1996;272:537-42.
23. 23. Kaslow R, Carrington N, Apple R, et al. Influence of combination of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996;2:405-11.
24. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:647-8.
25. 25. Alkhatib G, Combadiere C, Broder CC, et al. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophagetropic HIV-1. Science 1996;272:1955-8.
26. 26. Doranz BJ, Rucker J, Yi Y, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85:1149-58.
27. 27. Paxton W, Martin S, Tse D, et al. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat Med 1996;2:412-7.
28. 28. Huang Y, Paxton WA, Wolinsky S, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996; 2:1240-3.
29. 29. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-62.
30. 30. Smith MM, Dean M, Carrington C, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997;277:959-65.
31. 31. Donovan RM, Bush C, Markowitz N, et al. Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons. J Infect Dis 1996;174:401-4.
32. 32. Gallette D, Weissman D, Jackson R, et al. Effect of Mycohacterium tuberculosis on HIV replication. Role of immune activation. J Immunol 1996; 157:1271-8.
33. + lymphocyte count <50/μL. J Infect Dis 1995;171:829-36.
34. 34. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997;337:725-33.